Should Medical Marijuana Be Used To Treat Epileptic Children?
the Clinical Pain Advisor take:
Treating children with medical marijuana has always been a controversial topic, even as support for treating certain conditions with cannabis continues to grow. Some parents are now demanding that politicians and state legislators legalize the use of marijuana for treating epileptic children.
They believe that other medications have had limited success treating seizures and other severe conditions in their children. "I'm watching my daughter die every day," one parent told MSNBC in an interview. "I firmly believe that medical cannabis will help her."
"There's so much that I want for her right now that she just can't do," said another parent. "Just being able to go out and experience life, to be able to go out and play in the yard without fear of seizures starting."
Seventeen states have legalized the use of marijuana-derived cannabidiol (CBD) in children patients since 2014. These states include Utah, Wyoming, Wisconsin, Iowa, Missouri, Oklahoma, Texas, Louisiana, Mississippi, Alabama, Tennessee, Georgia, Florida, South Carolina, North Carolina, Kentucky and Virginia.
Anecdotal evidence suggests that CBD, the non-psychoactive component of the marijuana plant, helps some children with certain conditions. Tetrahydrocannabinol (THC), the part of the plant that produces a high, is also known to treat pain, nausea and insomnia.
Purchasing CBD isn't that simple. For example, some states don't define methods of access in their laws.
As of yet, the FDA has not approved any marijuana-related treatments. The regulatory agency warns parents of using untested treatments on children.
Treating children with medical marijuana has always been a controversial topic, even as support for treating certain conditions with cannabis continues to grow.
Clinical Pain Advisor Articles
- Opioid Use in Chronic Low Back Pain: A Population Study
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes
- Education Plus Exercise, Single Corticosteroid Injection Effective in Long Term for Gluteal Tendinopathy
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Naloxone Training Beneficial for PA Students
- Supervised Injection Sites Hailed as the Latest Strategy to Fight the Opioid Crisis